MedTrace Logo

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

NCT00409604 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-08-31

No results posted yet for this study

Summary

To determine whether the application of ventricular pacing can protect the human heart from damage resulting from a myocardial infarction

Conditions

  • Acute Myocardial Infarction

Interventions

DEVICE

Temporary RV VVI pacing

temporary pacing at the onset of revascularisation

Sponsors & Collaborators

  • Guidant Corporation

    lead INDUSTRY

Principal Investigators

  • JOhannes Waltenberger, Prof.Dr. · University Hospital of Maastricht (azM), P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00409604 on ClinicalTrials.gov